Related Experiment Video
Updated: Jul 18, 2026

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
Published on: December 2, 2014
Electrocardiographic left ventricular hypertrophy and arterial stiffness: the Ohasama study
Daisuke Watabe1, Junichiro Hashimoto, Rieko Hatanaka
1Department of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Science and Medicine, Aoba, Aramaki, Sendai, Japan.
Insights
Arterial stiffness, measured by pulse wave velocity (PWV), is independently linked to left ventricular hypertrophy (LVH) in the general population, even after accounting for blood pressure. This finding highlights arterial stiffness as a significant risk factor for LVH.
Area of Science:
- Cardiovascular Physiology
- Clinical Cardiology
- Biomedical Engineering
Background:
- The independent contribution of arterial stiffness to left ventricular hypertrophy (LVH) beyond blood pressure (BP) remains unclear.
- Investigating the relationship between pulse wave velocity (PWV) and LVH is crucial for understanding cardiovascular remodeling.
Purpose of the Study:
- To determine if arterial stiffness, assessed by brachial-to-ankle pulse wave velocity (baPWV), is independently associated with LVH.
- To explore the role of arterial stiffness as a risk factor for LVH in a large population cohort.
Main Methods:
- Brachial-to-ankle pulse wave velocity (baPWV) measured in 798 individuals.
- Left ventricular hypertrophy (LVH) diagnosed using electrocardiographic criteria (Cornell voltage-duration product or Sokolow-Lyon voltage).
- Development of a theoretical baPWV nomogram for a healthy group to calculate a PWV index; multivariate analyses performed.
Main Results:
- A predictive model for theoretical baPWV was established: baPWV = 0.20 x age + 0.13 x MAP + 0.05 x HR - 11.74 (R²=0.56).
- The PWV index was significantly higher in individuals with LVH compared to those without (P=.025).
- Increased baPWV was independently associated with LVH, along with Mean Arterial Pressure (MAP), and medications for hypertension and diabetes. A 1 SD increase in baPWV correlated with a 26% higher risk of LVH (P=.022).
Conclusions:
- Arterial stiffness is an independent predictor of electrocardiographically determined LVH in the general population.
- The prevalence of LVH increases linearly with the number of risk factors, including hypertension, diabetes, and elevated baPWV.
Background:
Whether arterial stiffness per se contributes to left ventricular hypertrophy (LVH) independently of blood pressure (BP) remains unknown. We examined the relationship between pulse wave velocity (PWV) and LVH in a large population.
Methods:
The PWV was measured between the brachial and ankle regions (baPWV) of 798 individuals. We diagnosed LVH using electrocardiographic criteria: Cornell voltage-duration product >2440 mm x msec or Sokolow-Lyon voltage >38 mm. The participants were initially separated into those with and without LVH [LVH(+) and LVH(-) groups, respectively]. To determine theoretical baPWV, we first constructed a nomogram for the LVH(-) group, calculated the PWV index (measured baPWV - theoretical baPWV) for each individual and then compared the two groups. We also examined the factors associated with LVH(+) using multivariate analyses.
Results:
Linear regression analysis revealed that the theoretical baPWV (m/sec) = 0.20 x age (years) + 0.13 x Mean arterial pressure (MAP) (mm Hg) + 0.05 x Heart rate (beats/min) - 11.74 (R(2) = 0.56). The PWV index was greater in the LVH(+) than in the LVH(-) group (P = .025). The baPWV was independently related to LVH(+) along with MAP, medication for hypertension, and for diabetes; a 1 SD (4.3 m/sec) increase in baPWV was associated with a 26% increase in the risk of LVH(+) (P = .022). When LVH(+) risk factors were defined as hypertension, diabetes, and high baPWV (> or =14.6 m/sec), the prevalence of LVH(+) linearly increased with the number of concomitant LVH(+) risk factors (P < .001).
Conclusions:
Arterial stiffness is independently related to electrocardiographically determined LVH in the general population.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Heart Failure II: Pathophysiology
